Pendulum is committed to developing novel interventions that target the human microbiome to improve the lives of patients suffering from a variety of diseases. Our targeted formulations of natural bacterial strains help to rebalance the microbiome which restores and improve one’s health.
2012
Pendulum Therapeutics raised undisclosed on March 20, 2024
Investors: Alumni Ventures